feed,title,long_url,short_url
Investing,Oncternal Therapeutics (ONCT) Soars 8.4%: Is Further Upside Left in the Stock?,https://investing.com/analysis/-200571900,
Investing,The ETF Portfolio Strategist: Downside Risk For Emerging Markets Continues,https://investing.com/analysis/-200571857,
